BRCA2 and cervical carcinoma: Although there are some targeted drugs that may be effective for cervical cancer, such as PARP inhibitors (for BRCA1 or BRCA2 mutations patients), EGFR tyrosine kinase inhibitors (for EGFR mutations patients), gene detection is still not widely used in China.